Micro Digital Co (305090) Fair Value & Analysis
Healthcare · KR · Market cap 45.3B KRW
Fair value as of: Jun 24, 2026
Analysis
Micro Digital Co (305090) currently trades at 2,250 KRW, while our model-based Fair Value estimate is 2,862 KRW — implying the stock looks roughly 27.2% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
About the company
Micro Digital Co., Ltd. develops, manufactures, and sells biomedical and bioprocess solutions in South Korea and internationally. The company offers biomedical lab instruments comprising Nabi, a UV/vis nano spectrophotometer; Mobi, a microplate spectrophotometer; Ubi-490, a UV/vis spectrophotometer; Ubi-600, a UV/vis standalone spectrophotometer; Ubi-800, a UV/vis double beam spectrophotometer; Lumi, a single tube luminometer; Lubi Plus, a microplate luminometer; and iSBS, an integrated sample banking system. It also provides biomedical in vitro diagnostic products consisting of DxBIC, an immunoassay automation platform. In addition, the company offers single-use bioreactor systems, such as CELBIC 5, CELBIC 25/50, CELBIC 100, CELBIC 200, CELBIC 500, and CELBIC 1000. Further, it provides bioprocess consumables, including 3D disposable cell culture bags; and 2D disposable storage, transfer, and sampling bags. The company serves CMOs and CDMOs, pharmaceutical companies, universities, r…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Micro Digital Co (305090) undervalued?
What is the fair value of 305090?
What is the quality score of 305090?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.